Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-003336-12Phase 4Active
Phase 4, randomised trial comparing Syntocinon, Vasostrict and Placebo (3 arms). Primary endpoint: Brain activity during processing of infant signals and threat to infant. Started Jan 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-003336-12.